Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: ResMed, Inc.

Market Cap 27.79B 24.11B 22.23B 20.83B 38.91B 2,660B 39.72B 265B 103B 1,282B 104B 102B 4,459B P/E Ratio 2026 *
18.2x
P/E Ratio 2027 * 16.4x
Enterprise Value 26.93B 23.37B 21.54B 20.18B 37.71B 2,578B 38.49B 257B 99.48B 1,243B 101B 98.9B 4,321B EV / Sales 2026 *
4.76x
EV / Sales 2027 * 4.29x
Free-Float
75.61%
Yield 2026 *
1.27%
Yield 2027 * 1.4%
1 day-0.61%
1 week-0.99%
Current month+0.96%
1 month-3.20%
3 months-19.89%
6 months-23.77%
Current year-20.13%
1 week 191.72
Extreme 191.72
197.34
1 month 180.26
Extreme 180.265
211.74
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 2013-02-28
Director of Finance/CFO 40 2026-05-03
Compliance Officer - 2017-12-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 53 2023-01-24
Chairman 83 1989-05-31
Date Insider Type Main position Quantity % Market Cap.
06-07Fiscal year

Chief Executive Officer

14,973 0.0103%
05-31Tax

General Counsel

-269 0.0002%
05-06Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-0.61%-0.99%-23.46%-9.90% 27.96B
-1.32%-1.32%+14.58%-8.21% 179B
+0.21%-1.41%-20.96%+32.02% 146B
-1.55%-3.13%-11.69%-23.19% 130B
-2.42%-3.44%-52.55%-8.01% 71.85B
-0.26%-1.93%+13.63%+1.97% 49.51B
-1.99%-0.72%-26.09%-34.28% 45.25B
-1.57%-6.37%+8.21%+11.88% 37.17B
-0.95%-4.44%+3.96%+44.31% 35.66B
+1.18%+1.10%-12.11%-16.33% 29B
Average -0.58%-2.05%-10.65%-0.97% 75.14B
Weighted average by Cap. -0.68%-2.04%-9.06%-0.76%

Financials

2026 *2027 *
Net sales 5.65B 4.91B 4.52B 4.24B 7.92B 541B 8.08B 53.94B 20.88B 261B 21.22B 20.76B 907B 6.1B 5.3B 4.88B 4.58B 8.55B 584B 8.73B 58.25B 22.55B 282B 22.92B 22.42B 980B
Net income 1.55B 1.35B 1.24B 1.16B 2.17B 148B 2.22B 14.8B 5.73B 71.57B 5.82B 5.7B 249B 1.7B 1.48B 1.36B 1.28B 2.39B 163B 2.44B 16.26B 6.29B 78.63B 6.4B 6.26B 273B
Net Debt -859M -746M -687M -644M -1.2B -82.26B -1.23B -8.2B -3.17B -39.65B -3.23B -3.16B -138B -1.58B -1.37B -1.26B -1.18B -2.21B -151B -2.26B -15.05B -5.83B -72.81B -5.92B -5.79B -253B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
26-06-11 192.39 $ -0.61% 1,070,930
26-06-10 193.57 $ -1.71% 1,039,160
26-06-09 196.94 $ +1.97% 1,024,460
26-06-08 193.14 $ -1.48% 1,033,936
26-06-05 196.04 $ +0.89% 1,536,653
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
192.39USD
Average target price
270.60USD
Spread / Average Target
+40.65%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!